Abeona Therapeutics (ABEO) Shares Outstanding (Diluted Average) (2011 - 2026)

Abeona Therapeutics' Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $56.6 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 13.75% year-over-year to $56.6 million; the TTM figure through Mar 2026 stood at $56.6 million (up 13.75% YoY), while the FY2025 annual figure was $66.1 million, up 61.12% from the prior year.
• Shares Outstanding (Diluted Average) was $56.6 million for Q1 2026 at Abeona Therapeutics, down from $66.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $66.1 million in Q4 2025 to a low of $5.8 million in Q2 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $35.1 million across 5 years, with a median of $32.9 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Diluted Average) surged 312.61% in 2023, then increased 13.75% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $7.9 million in 2022, then jumped by 171.96% to $21.4 million in 2023, then surged by 91.99% to $41.0 million in 2024, then soared by 61.12% to $66.1 million in 2025, then retreated by 14.39% to $56.6 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $56.6 million (Q1 2026), $66.1 million (Q4 2025), and $65.8 million (Q3 2025), per Business Quant data.